Imaging February 7, 2025

Cardiology in the Spotlight: Enterprise Imaging That Goes Beyond Radiology February 7, 2025

The future of medical imaging is about connection. Today’s healthcare challenges demand platforms that unify radiology, cardiology, digital pathology, genomics, and beyond into a seamless enterprise ecosystem—moving past the era of standalone systems and isolated workflows. A complete enterprise imaging solution allows us to move closer to an improved multidisciplinary collaboration, and a more comprehensive […]

Cardiology Pharmaceuticals February 6, 2025

PCSK9 Inhibitors: Sooner or Later? February 6, 2025

Sooner certainly seems to be better than later when it comes to treating LDL-C levels with the PCSK9 inhibitor evolocumab, and according to a recent JACC study, that’s especially true for older patients. Putting age before beauty, researchers conducted a prespecified analysis of the FOURIER-OLE study and found that among roughly 6.6k patients, evolocumab reduced […]

Cardiovascular Disease February 3, 2025

Cardiovascular Disease and Deaths On the Rise February 3, 2025

Another year, another AHA report reasserting heart disease’s dominance as the number one killer in the United States, and the latest data shows that this trend is still gaining momentum. Four years after that goal’s due date, the burden of CVD in the U.S. is at an all time high, with 942k cardiovascular disease-related deaths […]

Structural Heart January 30, 2025

Why Mechanical AVR Valves Still Matter January 30, 2025

A presentation at this year’s Society of Thoracic Surgeons (STS) conference suggests mechanical valves might lead to better survival compared to bioprosthetic valves in patients aged 60 or younger undergoing SAVR even though it seems like they’re going out of style. Researchers examined STS registry data on ~109k patients ages 40 to 75 years who […]

More Stories

Pharmaceuticals January 27, 2025

Abelacimab Stops Bleeding, But Stroke Impact Uncertain January 27, 2025

Anthos Therapeutics published the full results of its Phase 2 AZALEA-TIMI 71 trial for its novel Factor XI inhibitor, abelacimab, confirming the drug’s lower bleeding risks, but leaving researchers uncertain about its ability to prevent stroke in AFib patients. To see if abelacimab was a safer alternative, researchers randomized 1,287 AFib patients at risk of […]

Obesity Care January 23, 2025

The Potential Risks of GLP-1s January 23, 2025

Although GLP-1s have proven to significantly help with weight loss and cardiometabolic disorders, a new Nature Medicine study shed light on the drugs’ potential side-effects. To tackle this problem, researchers compared Veteran’s Affairs data on 2 million T2D patients (2017-2023) taking either GLP-1s, DPP4is, SGLT2is, or usual care antihyperglycemics over a 3.68 year follow-up. Starting […]

Heart Failure January 16, 2025

The Finer Points of FINEARTS-HF January 16, 2025

Bayer’s FINEARTS-HF study revealed that finerenone could be poised to become the next big heart failure treatment at ESC 2024, and a new series of JACC sub-studies just further strengthened its case. The first of the featured studies revealed that patients treated soon after experiencing a worsening heart failure (WHF) event saw greater benefits. The […]

Cardiac Imaging January 13, 2025

AI-CCTA Beats SPECT, Again January 13, 2025

A recent study out of UCLA seemed to add to the body of evidence supporting AI-assisted CCTA as an alternative to SPECT for diagnosing obstructive coronary artery disease, although holes in the study suggest that CCTA AI has more to prove To determine if AI-CCTA could hold its own, researchers analyzed CCTA images from 175 […]

Artificial Intelligence January 9, 2025

AI-ECG’s 2025 Kickoff January 9, 2025

The buzz around artificial intelligence’s impact on cardiology keeps growing louder, and that’s proving to be particularly true in the AI-ECG segment, with 2025 already off to a strong start from ECG startups and researchers alike. One pertinent example is AccurKardia’s recent FDA breakthrough designation for its ECG-based, AI-powered AK+ Guard hyperkalemia detection software.  Tackling […]

Controversies January 6, 2025

Cardiologists Busted for Overbilling Nationwide January 6, 2025

Adding to a relentless trend of Medicare schemes, 16 cardiology practices agreed to pay more than $17.7M to resolve allegations that they overbilled for diagnostic radiopharmaceuticals and violated the False Claims Act. The DOJ accused these practices of reporting “inflated acquisition costs” to Medicare for materials needed to perform cardiovascular imaging. The three largest settlements […]

Get twice-weekly insights on the biggest stories shaping cardiology.

You might also like..

Select All

You're signed up!

It's great to have you as a reader. Check your inbox for a welcome email.

-- The Cardiac Wire Team

You're all set!